bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.03.22.485140

Decoding functional high-density lipoprotein particle surfaceome interactions

Abstract

High-density lipoprotein (HDL) is a mixture of complex particles mediating reverse cholesterol transport in the human body and several cytoprotective activities. Despite its relevance for human health, many aspects of HDL-mediated lipid trafficking and cellular signaling remain elusive at the molecular level. During HDLs journey throughout the body, its function is mediated through interactions with cell surface receptors on different cell types. Using four different cellular model systems HDL is interacting with, we comparatively analyzed their surfaceomes to define the HDL receptome. Surfaceome analysis of EA.hy926, HEPG2, foam cells, and human aortic endothelial cells (HAEC) revealed the main currently known HDL-receptor scavenger receptor B1 (SCRB1), as well as 154 shared cell surface receptors representing potential HDL interaction receptor candidates. Since vascular endothelial growth factor A (VEGF-A) was recently found as a regulatory factor of transendothelial transport of HDL, we next analyzed the VEGF modulated surfaceome of HAEC using auto-CSC technology. VEGF-A treatment led to a remodeling of the surfaceome of HAEC cells including the previously reported higher surfaceome abundance of SCRB1 upon treatment. 165 additional receptors were found on HAEC upon VEGF-A treatment representing SCRB1 co-regulated receptors potentially involved in HDL function. Using HATRIC-based ligand receptor capturing (HATRIC-LRC) technology on human endothelial cells, we specifically aimed for the identification of other bona fide (co-)receptors of HDL beyond SCRB1. HATRIC-LRC enabled, next to SCRB1, the identification of the receptor tyrosine-protein kinase Mer (MERTK), which we show is directly contributing to endothelial HDL binding and uptake. Subsequent proximity ligation assays (PLA) demonstrate furthermore the spatial vicinity of MERTK and SCRB1 on the endothelial cell surface. The data shown provide direct evidence for a complex and dynamic HDL receptome and that receptor nanoscale organization may influence functional HDL binding and uptake. List of human gene and protein names discussed in the paperABCA1: Phospholipid-transporting ATPase ABCA1 (ABCA1) ABCA7: Phospholipid-transporting ATPase ABCA7 (ABCA7) ABCG1: ATB-binding cassette G1 (ABCG1) ACVR2A: Activin receptor type-2A (AVR2A) APOA1: Apolipoprotein A1 (APOA1) APOB: Apolipoprotein B (APOB) APOC3: Apolipoprotein C-III (APOC3) APOH: Beta-2-glycoprotein 1 (APOH) APOM: Apolipoprotein M (APOM) ATP5MF: Ecto-F1-ATPase (ATPK) CD4: T-cell surface glycoprotein CD4 (CD4) CD14: Monocyte differentiation antigen CD14 (CD14) CD36: platelet glycoprotein 4 (CD36) EGFR: Epidermal growth factor receptor (EGFR) ITGAM: Integrin alpha-M (ITAM) ITGAV: Integrin alpha-V (ITAV) KDR: Vascular endothelial growth factor receptor 2 (VGFR2) KIT: Mast/stem cell growth factor receptor Kit (KIT) MEGF8: Multiple epidermal growth factor-like domains protein 8 (MEGF8) MEGF10: Multiple epidermal growth factor-like domains protein 10 (MEGF10) MERTK: tyrosine-protein kinase Mer (MERTK) MRC2: C-type mannose receptor 2 (MRC2) MSR1: Macrophage scavenger receptor types I and II (MSRE) PCDHAC1: Protocadherin alpha-C1 (PCDC1) PLTP: Phospholipid transfer protein (PLTP) S1PR1: sphingosine 1-phosphate receptor 1 (S1PR1) S1PR2: sphingosine 1-phosphate receptor 2 (S1PR2) S1PR3: sphingosine 1-phosphate receptor 3 (S1PR3) SCARA3: Scavenger receptor class A member 3 (SCAR3) SCARB1: Scavenger receptor B1 (SCRB1) SLC8A3: Sodium/calcium exchanger 2 (NAC2) TF: Transferrin (TRFE) TFRC: Transferrin receptor protein 1 (TFR1) VEGFA: vascular endothelial growth factor A (VEGF-A) Significance statementA molecular understanding of the high-density lipoprotein (HDL) receptome would provide the rational basis for modulating reverse cholesterol transport. Here we used cellular model systems mimicking tissues involved in HDL-trafficking and reverse cholesterol transport to define the HDL receptome. The receptor tyrosine-protein kinase Mer (MERTK) was identified as a novel mediator of HDL binding and uptake in human aortic endothelial cells. Endothelial MERTK resides within the surfaceome proximal to SCRB1 representing a potential co-receptor. The molecular nanoscale organization of the cell-specific surfaceome may influence cellular HDL interactions and functionality.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Frey, K., Goetze, S., Rohrer, L., von Eckardstein, A., Wollscheid, B.. 2022-03-22. Decoding functional high-density lipoprotein particle surfaceome interactions. https://doi.org/10.1101/2022.03.22.485140

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A G-Quadruplex Containing First Intron Harbors a Functional Polyadenylation Signal in TP53

First introns of mammalian genes are often longer than other introns and may contain regulatory elements, suggesting that they may have roles in gene regulation. We detected a previously unannotated, low abundance intronic transcript, TP53-INT1, using long-read direct RNA sequencing data. TP53-INT1 has low coding potential and terminates within the first and longest intron of TP53. The transcript structure and 3'-end were validated by independent experimental and in silico evidence. We identified a canonical polyadenylation signal upstream of the transcript termination site and demonstrated its functionality using reporter assays. Furthermore, a potential G-quadruplex (G4)-forming sequence was identified upstream of this polyadenylation signal. The G4-forming potential was confirmed using spectroscopic and thermal stability analyses. Complementing the in vitro characterizations, treatment with Pyridostatin, a G4-stabilizing drug, was associated with decreased TP53 expression. Together, these findings characterize a previously unannotated TP53 intronic transcript and reveal a local genomic context combining accessible chromatin, a functional polyadenylation signal, and a potential G4-forming sequence that may influence full-length transcription.

molecular biology↗

LOca-1: A minimal calcium-activated arginyl-specific orthocaspase from the Loki's Castle hydrothermal vent field

Orthocaspases are prokaryotic homologs of metacaspases within the C14 family of cysteine proteases, yet their biochemical properties and cellular roles remain poorly understood. Here, we report the discovery and comprehensive characterization of LOca-1, a metagenome-derived orthocaspase from the Loki's Castle hydrothermal vent field. LOca-1 consists primarily of a single, conserved p20 catalytic domain and undergoes calcium-dependent activation through cleavage at a conserved arginine residue. Once activated, LOca-1 displays strict arginyl-specific proteolytic activity and strong selectivity for residues surrounding the cleavage site. The enzyme is both thermoactive and thermostable, exhibiting maximal activity at 65 {degrees}C and a melting temperature of approximately 72 {degrees}C. Structural modelling revealed conservation of the catalytic core relative to plant metacaspases despite substantial sequence divergence. To our knowledge, LOca-1 is only the second biochemically characterized orthocaspase and the first reported from a deep-sea hydrothermal vent environment. LOca-1 expands the known biochemical diversity of prokaryotic metacaspase homologs and provides insights into the properties of a minimal p20-domain orthocaspase. Together, our findings establish LOca-1 as a thermostable, calcium-activated arginyl-specific orthocaspase and provide a foundation for future studies of orthocaspase function in prokaryotes.

molecular biology↗

A TMEM175 Mutation Disrupts the Lysosomal-Mitochondrial Axis Causing Short QT Syndrome and Sudden Cardiac Death

Short QT Syndrome (SQTS) is a rare cardiac channelopathy characterized by abnormally short QTc intervals and increased sudden cardiac death (SCD) risk. Only 20-30% of SQTS cases have been linked to genetic mutations, typi-cally in surface membrane ion channels. We identified a novel lysosomal TMEM175 gene mutation (p.Arg377His) in 7 patients in a family with SQTS and SCD. Genetic analyses, including whole exome sequencing in the family and rare-variant burden testing in [~]118,000 UK Biobank participants, sug-gested an association between TMEM175 rare variants and QT interval short-ening. Functional studies in CRISPR-engineered mice and patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) revealed that TMEM175R377H causes shortened QT intervals and hastened repolariza-tion, respectively, as well an increased arrhythmia susceptibility. Isolated TMEM175R377H cardiomyocytes showed action potential duration (APD) abbre-viation, confirmed in whole TMEM175R377H mouse hearts and patient-specific iPSC-CM monolayers. In silico and electron microscopy studies showed that TMEM175R377H disrupts lysosomal-mitochondrial interactions, leading to mito-chondrial dysfunction, as evidenced by the reduced maximal respiration and spare respiratory capacity, with reduced ATP production, IKATP activation, and APD shortening. This mutation represents the first non-sarcolemmal ion chan-nel defect associated with SQTS and high SCD risk, potentially expanding the genetic landscape of the disease.

molecular biology↗